Supported by a grant from Iceland, Liechtenstein and Norway

Welcome to NanoCHEM - Innovative Nanoparticles-based Chemotherapy for Acute Myeloid Leukemia

Nanotechnology applied to the medical field or nanomedicine is a very fast growing research field having a strong interdisciplinary character. It aims to bring together physicists, biologists, chemists, physicians and pharmacists in order to apply latest nanotechnology achievements for biomedical applications. At the nanoscale, the new physical properties afforded by the nano-objects offer not only different but also better ways of detecting, managing, treating and in certain cases, preventing disease

In the present research project we propose to further extend the very recent advancements in biotechnology with two precise aims: development of new follow-up methodology for patients that receive tyrosine kinase inhibitors using state-of-the-art mass spectrometry, as well as the follow-up of a previous research collaboration between Romanian and Norwegian partners regarding gold nanoparticle (GNP)-based DDA of tyrosine kinase inhibitors for the chemotherapy of acute myeloid leukemia. The technical goals are also supplemented by a teaching activity, in which we wish to bring an interdisciplinary solution to this disease, as well as strengthen the collaboration between various fields in science. Training of the young investigators in high technology research protocols, with a special emphasis on the training of young doctors, resident physicians, PhD students and post-doctoral researchers that are of Roma ethnic minority will represent a special feature of the project, in order to help combat discrimination and intolerance. Thus, their integration in the European scientific community will be supported.